Use of psychotropic drugs and alcohol among non-institutionalised elderly adults in Germany

Pharmacopsychiatry

Volumn 41, Issue 6, 2008, Pages 242-251

  Du, Y ^a   Scheidt Nave, C ^a   Knopf, H ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BETAHISTINE; CAFFEINE; CARBAMAZEPINE; CLONAZEPAM; DECARBOXYLASE INHIBITOR; DIHYDROCODEINE; DIHYDROERGOTAMINE; HYPNOTIC AGENT; LEVODOPA; MELPERONE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NITRAZEPAM; OXAZEPAM; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SULPIRIDE; TRAMADOL; TRIMIPRAMINE; UNINDEXED DRUG; VALERIAN;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; DEMOGRAPHY; DRUG USE; EUROPE; FEMALE; GENDER; GERMANY; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING; SOCIAL STATUS;

AGE FACTORS; AGED; ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DRUG UTILIZATION; FEMALE; GERMANY; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; REGRESSION ANALYSIS; RURAL POPULATION; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 58049095767     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1083791     Document Type: Article

References (53)

1. Adams WL. Potential for adverse drug-alcohol interactions among retirement community residents. J Am Geriatr Soc 1995; 43: 1021-1025
2. Alonso J, Angermeyer MC, Bernert S et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 55-64
3. Angermeyer MC, Matschinger H. Public attitudes towards psychotropic drugs: have there been any changes in recent years? Pharmacopsychiatry 2004; 37: 152-156
4. Antonijoan RM, Barbanoj MJ, Torrent J et al. Evaluation of psychotropic drug consumption related to psychological distress in the elderly: hospitalized vs. nonhospitalized. Neuropsychobiology 1990; 23: 25-30
5. Aparasu R, Mort J, Brandt H. Psychotropic medication expenditures for community-dwelling elderly persons. Psychiatr Serv 2003; 54: 739-742
6. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc 2003; 51: 671-677
7. Bellach B, Knopf H, Thefeld W. Der Buncles-Gesundheitssurvey 1997/ 98 (The National Health Survey 1997/98). Gesundheitswesen 1998; 60 (special issue 2): 59-68
8. Benkert O, Graf-Morgenstern M, Hillert A et al. Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J Nerv Ment Dis 1997; 185: 151-158
9. Blazer DG, Hybels CF, Simonsick EM et al. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psychiat 2000; 157: 1099-1094
10. Burger M, Bronstrup A, Pietrzik K. Derivation of tolerable upper alcohol intake levels in Germany: a systematic review of risks and benefits of moderate alcohol consumption. Prev Med 2004; 39: 111-127
11. Burger M, Mensink G, Bronstrup A et al. Alcohol consumption and its relation to cardiovascular risk factors in Germany. Eur J Clin Nutr 2004; 58: 605-614
12. Burger M, Mensink GB. High alcohol consumption in Germany: results of the German National Health Interview and Examination Survey 1998. Public Health Nutt 2004; 7: 879-884
13. Burggraf GW. Are psychotropic drugs at therapeutic levels a concern for cardiologists? Can J Cardiol 1997; 13: 75-80
14. Lima McS de, Dunn J, Novo IP et al. Gender differences in the use of alcohol and psychotropics in a Brazilian population. Subst Use Misuse 2003; 38: 51-65
15. Dealberto MJ, Seeman T, MacAvay GJ et al. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol 1997; 50: 357-364
16. Fick DM, CooperJW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724
17. Field TS, Gurwitz JH, Harrold LR et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52: 1349-1354
18. Gleason PP, Schulz R, Smith NL et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998; 13: 243-250
19. Gustafsson TM, Isacson DGL, Thorslund M et al. Factors associated with psychotropic drug use among the elderly living at home. J Appl Gerontol 1996; 15: 238-254
20. Hansen DG, Rosholm JU, Gichangi A et al. Increased use of antidepressants at the end of life: population-based study among people aged 65 years and above. Age Ageing 2007; 36: 449-454
21. Harrington C, Tompkins C, Curtis M et al. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 1992; 32: 822-833
22. Heckman GA, Misiaszek B, Merali F et al. Association between psychotropic drug use and heart failure therapy in elderly long-term care residents. J Am Geriatr Soc 2006; 54: 1973-1975
23. Hoffmeister H, Schelp FP, Mensink GB et al. The relationship between alcohol consumption, health indicators and mortality in the German population. Int J Epidemiol 1999; 28: 1066-1072
24. Ilomäki J, Korhonen MJ, Enlund H et al. Risk drinking behavior among psychotropic drug users in an aging Finnish population: The FinDrink study. Alcohol 2008, in press, corrected proof
25. John U, Baumeister SE, Volzke H et al. Sedative, hypnotic, anxiolytic and opioid medicament use and its co-occurrence with tobacco smoking and alcohol risk drinking in a community sample. BMC Public Health 2007; 7: 337
26. Kessler RC, Merikangas KR. The National Comorbidity Survey Replication (NCS-R): background and aims. Int J Methods Psychiatr Res 2004; 13: 60-68
27. Kirby M, Denihan A, Bruce I et al. Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry 1999; 14: 280-284
28. Kraus L, Bloomfield K, Augustin R et al. Prevalence of alcohol use and the association between onset of use and alcohol-related problems in a general Population sample in Germany. Addiction 2000; 95: 1389-1401
29. Kunig G, Datwyler S, Eschen A et al. Unrecognised long-lasting tramadol-induced delirium in two elderly patients. A case report. Pharmacopsychiatry 2006; 39: 194-199
30. Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf 2003; 2: 233-247
31. Linden M, Bar T, Helmchen H. Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). Int Psychogeriatr 2004; 16: 461-480
32. Linjakumpu T, Hartikainen S, Klaukka T et al. Psychotropics among the home-dwelling elderly - increasing trends. Int J Geriatr Psychiatry 2002; 17: 874-883
33. Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 2004; 3: 485-493
34. Meyer C, Rumpf HJ, Hapke U et al. Prevalence of alcohol consumption, abuse and dependence in a country with high per capita consumption: findings from the German TACOS study. Transitions in Alcohol Consumption and Smoking. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 539-547
35. Mirand AL, Welte JW. Alcohol consumption among the elderly in a general population, Erie County, New York. Am J Public Health 1996; 86: 978-984
36. Moore AA, Whiteman EJ, Ward KT. Risks of combined alcohol/ medication use in older adults. Am J Geriatr Pharmacother 2007; 5: 64-74
37. Ohayon MM, Caulet M, Priest RG et al. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51: 273-283
38. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63: 817-825
39. Paterniti S, Dufouil C, Bisserbe JC et al. Anxiety, depression, psychotropic drug use and cognitive impairment. Psychol Med 1999; 29: 421-428
40. Paulose-Ram R, Jonas BS, Orwig D et al. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. J Clin Epidemiol 2004; 57: 309-317
41. Percudani M, Barbui C, Fortino I et al. Antipsychotic drug prescribing in the elderly is cause for concern. Int Clin Psychopharmacol 2004; 19: 347-350
42. Pringle KE, Ahern FM, Heller DA et al. Potential for alcohol and prescription drug interactions in older people. J Am Geriatr Soc 2005; 53: 1930-1936
43. Schwab M, Roder F, Aleker T et al. Psychotropic drug use, falls and hip fracture in the elderly. Aging (Milano) 2000; 12: 234-239
44. Simoni-Wastila L, Yang HK. Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother 2006; 4: 380-394
45. Simoni-Wastila L, Zuckerman IH, Singhal PK et al. National estimates of exposure to prescription drugs with addiction potential in community-dwelling elders. Subst Abus 2005; 26: 33-42
46. Sonntag A, Matschinger H, Angermeyer MC et al. Does the context matter? Utilization of sedative drugs in nursing homes - a multilevel analysis. Pharmacopsychiatry 2006; 39: 142-149
47. Steinman MA, Landefeld CS, Rosenthal GE et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516-1523
48. Swartz M, Landerman R, George LK et al. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. Am J Public Health 1991; 81: 592-596
49. Taylor S, MacCracken CF, Wilson KC et al. Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. Br J Psychiatry 1998; 173: 433-438
50. The WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-2590
51. Ufer M, Meyer SA, Junge O et al. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007; 16: 1153-1160
52. Voyer P, Cohen D, Lauzon S et al. Factors associated with psychotropic drug use among community-dwelling older persons: a review of empirical studies. BMC Nurs 2004; 31: 3
53. Weyerer S, Dilling H. Psychiatric and physical illness, sociodemographic characteristics, and the use of psychotropic drugs in the community: results from the upper Bavarian field study. J Clin Epidemiol 1991; 44: 303-311